Maree Zinzley, Manager Approvals, of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”) that the following variation application has been made to a registered trade name product under section 9(2) of the Act:

Trade Name: Cervidae Oral

Reference: A011849

Active Ingredients and Concentrations:

moxidectin 4g/L
oxfendazole 180g/L
levamisole hydrochloride 120g/L

Formulation Type: Aqueous suspension

Current Claims:

For the treatment and control of gastrointestinal parasites in deer. Safety has not been established in deer less than 30kg or under six months of age. Doses up to 2x recommended do not cause signs of toxicity in healthy deer over 30kg and six months old. Doses above 2x may be harmful. Safety has not been assessed in deer under six months old.

Proposed New Claims (changes in bold):

Cervidae oral is safe to use at the recommended dose rate in young deer from four weeks of age and 20kg bodyweight.

Doses up to 2x recommended do not cause signs of toxicity in healthy deer over 20kg and four weeks of age. Doses above 2x may be harmful.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

1. must state in full the reasons for making the submission;
2. may state any decision sought on that application; and
3. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

1. where submissions on this application are to be sent;
2. where requests for copies of the public information relating to the application can be sent;
3. where public information relating to the application can be viewed; and
4. the director-general’s address for service:

ACVM Group, Ministry for Primary Industries, Charles Fergusson Building, 34–38 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140. Email: acvm.consultation@mpi.govt.nz.

The applicant’s address for service is:

Nexan Corporation Limited, 16A Ormiston Road, East Tamaki, Auckland. Postal Address: PO Box 217234, Botany Junction, Auckland 2164.

Dated at Wellington this 23rd day of February 2022.

MAREE ZINZLEY, Manager Approvals, Ministry for Primary Industries (acting under delegated authority).